Progynova

In the US, Progynova is a member of the drug class estrogens and is used to treat Atrophic Urethritis, Atrophic Vaginitis, Breast Cancer - Palliative, Hypoestrogenism, Oophorectomy, Osteoporosis, Postmenopausal Symptoms, Primary Ovarian Failure and Prostate Cancer.

UK matches:

• Progynova TS 100 micrograms/24 hours Transdermal Patch
• Progynova TS 50
• Progynova 1mg (SPC)
• Progynova 2mg (SPC)
• Progynova TS 100 micrograms/24 hours Transdermal Patch (SPC)
• Progynova TS 50 micrograms/24 hours Transdermal Patch (SPC)

Ingredient matches for Progynova

Estradiol

Estradiol is reported as an ingredient of Progynova in the following countries:

• Argentina

Estradiol 17ß-valerate (a derivative of Estradiol) is reported as an ingredient of Progynova in the following countries:

• Algeria


• Antigua & Barbuda


• Aruba


• Australia


• Austria


• Bahamas


• Barbados


• Belgium


• Belize


• Bermuda


• Cayman Islands


• Chile


• China


• Colombia


• Dominican Republic


• Ethiopia


• Finland


• France


• Germany


• Grenada


• Guyana


• Haiti


• Hong Kong


• Indonesia


• Israel


• Italy


• Jamaica


• Luxembourg


• Malaysia


• Malta


• Netherlands


• Netherlands Antilles


• New Zealand


• Norway


• Peru


• Philippines


• Russian Federation


• Saint Lucia


• Singapore


• South Africa


• Spain


• Suriname


• Switzerland


• Taiwan


• Thailand


• Trinidad & Tobago


• United Kingdom


• Vietnam

Estradiol hemihydrate (a derivative of Estradiol) is reported as an ingredient of Progynova in the following countries:

• Malta


• United Kingdom

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.